Possible involvement of cerebroside sulfate in opiate receptor binding
- PMID: 203492
Possible involvement of cerebroside sulfate in opiate receptor binding
Abstract
Cerebroside sulfate (CS) appears to fulfill most of the structural requirements of a hypothetical opiate receptor. It possesses many of the properties that are thought to be necessary for the identification of an "opiate receptor," exhibiting high affinity and stereoselective binding to a number of narcotic drugs. Although these properties are insufficient to establish identity of the receptor, it is highly significant that the affinity of this binding can be correlated with the analgetic potency of these drugs in both man and rodents. CS is an endogenous component of brain tissue, and a partially purified opiate receptor from mouse brain has been found to be CS. Other experiments indicate that reduced availability of brain CS decreases the analgetic effects of morphine and this is accompanied by a reduction in number of binding sites, suggesting that the interaction of opiates with CS observed in vitro may also have importance in vivo. CS was also found to be a component of the opiate receptor after marking with 125I-labeled diazosulfanilic acid. The possibility that CS or the SO4-2 group of this lipid may be the "anionic site" of the opiate receptor should be considered.
Similar articles
-
Evidence for the involvement of cerebroside sulfate in opiate receptor binding: Studies with Azure A and jimpy mutant mice.J Pharmacol Exp Ther. 1978 Nov;207(2):458-68. J Pharmacol Exp Ther. 1978. PMID: 213557
-
Interaction of diazosulfanilic acid and the opiate receptor: inhibition of specific binding to synaptic membranes and labeling of a membrane lipid stereospecifically protected by opioids.Mol Pharmacol. 1981 May;19(3):355-66. Mol Pharmacol. 1981. PMID: 6267443 No abstract available.
-
Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.J Pharmacol Exp Ther. 1980 Sep;214(3):455-62. J Pharmacol Exp Ther. 1980. PMID: 6105201
-
Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone.J Pharmacol Exp Ther. 1996 Oct;279(1):172-6. J Pharmacol Exp Ther. 1996. PMID: 8858990
-
Introduction to the opiate receptor.Fed Proc. 1978 Feb;37(2):139-40. Fed Proc. 1978. PMID: 203490 Review. No abstract available.
Cited by
-
beta-Endorphin: formation of alpha-helix in lipid solutions.Proc Natl Acad Sci U S A. 1979 Aug;76(8):3656-9. doi: 10.1073/pnas.76.8.3656. Proc Natl Acad Sci U S A. 1979. PMID: 226973 Free PMC article.
-
Substance P: model studies of its binding to phospholipids.Naunyn Schmiedebergs Arch Pharmacol. 1979 Apr;306(3):189-94. doi: 10.1007/BF00507102. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 38406
-
Substance P: characteristics of binding to synaptic vesicles of rat brain.Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):45-51. doi: 10.1007/BF00515592. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 34108
-
On the role of sulfolipids in mammalian metabolism.Mol Cell Biochem. 1985 Feb;66(1):87-95. doi: 10.1007/BF00231827. Mol Cell Biochem. 1985. PMID: 2580222 Review.
-
Binding of imipramine and cocaine to a model lipid membrane: comparison with binding to brain membranes.Neurochem Res. 1984 Jul;9(7):965-77. doi: 10.1007/BF00964527. Neurochem Res. 1984. PMID: 6504231